Richard W. Tothill

Richard W. Tothill

Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications

Whole genome and exome sequencing of pancreatic neuroendocrine tumour to investigate PRRT response.

Whole genome and exome sequencing of pancreatic neuroendocrine tumour to investigate PRRT response.

Journal: Endocrine-related cancer
Published: April 20, 2026

Duplex-Specific DNase Signal Amplification Allows Attomolar Electrochemical Detection of MicroRNAs.

Duplex-Specific DNase Signal Amplification Allows Attomolar Electrochemical Detection of MicroRNAs.

Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: July 03, 2025

Pathologist-initiated whole genome and transcriptome sequencing demonstrates diagnostic utility in resolving difficult-to-diagnose tumors.

Pathologist-initiated whole genome and transcriptome sequencing demonstrates diagnostic utility in resolving difficult-to-diagnose tumors.

Journal: Genome medicine
Published: March 12, 2025

Recent progress in molecular classification of phaeochromocytoma and paraganglioma.

Recent progress in molecular classification of phaeochromocytoma and paraganglioma.

Journal: Best practice & research. Clinical endocrinology & metabolism
Published: September 13, 2024

Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary.

Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary.

Journal: Nature communications
Published: August 08, 2024

The evolution of molecular management of carcinoma of unknown primary.

The evolution of molecular management of carcinoma of unknown primary.

Journal: Current opinion in oncology
Published: July 15, 2024

Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles.

Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles.

Journal: Research square
Published: July 09, 2024

Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles.

Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles.

Journal: Nature communications
Published: June 15, 2024

Evaluating the Utility of 18F-FDG PET/CT in Cancer of Unknown Primary.

Evaluating the Utility of 18F-FDG PET/CT in Cancer of Unknown Primary.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 22, 2024

Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary origin.

Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary origin.

Journal: BMC cancer
Published: February 14, 2024

Unravelling mutational signatures with plasma circulating tumour DNA.

Unravelling mutational signatures with plasma circulating tumour DNA.

Journal: Nature communications
Published: January 25, 2024

Disruption of metazoan gene regulatory networks in cancer alters the balance of co-expression between genes of unicellular and multicellular origins.

Disruption of metazoan gene regulatory networks in cancer alters the balance of co-expression between genes of unicellular and multicellular origins.

Journal: Genome biology
Published: August 08, 2023
Showing 1-12 of 75

Last Updated: 09/26/2026